このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Skylight Health Group マネジメント

マネジメント基準チェック /34

Skylight Health Group'sの CEO はPrad Sekarで、 Feb2019年に任命され、の在任期間は 4.5年です。は、会社の株式の4.71%を直接所有しており、その価値はCA$ 38.87K 。経営陣と取締役会の平均在任期間はそれぞれ2.5年と4.5年です。

主要情報

Prad Sekar

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	4.5yrs
CEOの所有権	4.7%
経営陣の平均在職期間	2.5yrs
取締役会の平均在任期間	4.5yrs

経営陣の近況

Recent updates

Rainbows and Unicorns: Skylight Health Group Inc. (CVE:SLHG) Analysts Just Became A Lot More Optimistic

Aug 18

What You Need To Know About The Skylight Health Group Inc. (CVE:SLHG) Analyst Downgrade Today

Apr 02

CEO報酬分析

Skylight Health Group の収益と比較して、Prad Sekar の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2022	n/a	n/a	-CA$26m
Jun 30 2022	n/a	n/a	-CA$27m
Mar 31 2022	n/a	n/a	-CA$27m
Dec 31 2021	CA$439k	CA$374k	-CA$22m
Sep 30 2021	n/a	n/a	-CA$23m
Jun 30 2021	n/a	n/a	-CA$20m
Mar 31 2021	n/a	n/a	-CA$14m
Dec 31 2020	CA$2m	CA$312k	-CA$12m
Sep 30 2020	n/a	n/a	-CA$8m
Jun 30 2020	n/a	n/a	-CA$9m
Mar 31 2020	n/a	n/a	-CA$10m
Dec 31 2019	CA$427k	CA$162k	-CA$11m
Sep 30 2019	n/a	n/a	-CA$8m
Jun 30 2019	n/a	n/a	-CA$7m
Mar 31 2019	n/a	n/a	-CA$6m
Dec 31 2018	CA$403k	CA$186k	-CA$4m
Sep 30 2018	n/a	n/a	-CA$2m
Dec 31 2017	CA$94k	CA$94k	-CA$1m

報酬と市場: Pradの総報酬がCanadian市場の同規模の企業と比較して妥当かどうかを判断するにはデータが不十分です。

報酬と収益: Pradの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Prad Sekar

4.5yrs

在職期間

CA$439,235

報酬

Mr. Pradyum Sekar, also known as Prad, is the Co-Founder of Skylight Health Group Inc. (formerly known as CB2 Insights Inc.) and has been its Chief Executive Officer, Secretary and Director since February...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Pradyum Sekar	Co-Founder	4.5yrs	CA$439.24k	4.71% CA$ 38.9k
Kashaf Qureshi	Co-Founder	4.5yrs	CA$439.24k	4.32% CA$ 35.6k
Kit Brekhus	Chief Medical Officer	2.1yrs	CA$747.22k	データなし
Farooq Akhter	Interim Chief Financial Officer	1.2yrs	データなし	0.014% CA$ 112.0
Laura Corona	Senior Vice President of Operation	1.2yrs	データなし	データなし
Dan Thompson	Chief Corporate Officer	4yrs	データなし	データなし
Georges Feghali	Advisor	2.5yrs	データなし	データなし

2.5yrs

平均在職期間

経験豊富な経営陣: SLHGの経営陣は経験豊富であると考えられます ( 2.5年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Pradyum Sekar	Co-Founder	4.5yrs	CA$439.24k	4.71% CA$ 38.9k
Kashaf Qureshi	Co-Founder	4.5yrs	CA$439.24k	4.32% CA$ 35.6k
Norton Singhavon	Independent Director	4.5yrs	CA$122.80k	0.41% CA$ 3.4k
Grace Mellis	Independent Director	2.6yrs	CA$111.40k	0.10% CA$ 848.6
Peter Cummins	Independent Director	4.1yrs	CA$117.33k	0.30% CA$ 2.4k

4.5yrs

平均在職期間

経験豊富なボード: SLHGの取締役会は経験豊富であると考えられます ( 4.5年の平均在任期間)。

Skylight Health Group マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Skylight Health Group Inc. Announces the Resignation of Tom Brogan as Board of Directors

Skylight Health Group Inc. Announces Board Changes

Skylight Health Group Inc. Appoints Farooq Akhter as Interim Chief Financial Officer, Effective June 15, 2022

High number of new directors

Independent Chairman of the Board recently bought CA$59k worth of stock

President recently bought CA$54k worth of stock

Recent updates

Skylight Health Group Inc. Announces the Resignation of Tom Brogan as Board of Directors

Skylight Health Group Inc. announced that it has received CAD 6.762 million in funding

Skylight Health Group Inc. to Report Q3, 2022 Results on Nov 16, 2022

Skylight Health Group Inc. announced that it expects to receive CAD 6.861 million in funding

Nasdaq Suspends Skylight Health Group

Consensus revenue estimates increase by 17%

Skylight Health Group Inc. announced that it has received CAD 2.355 million in funding

Rainbows and Unicorns: Skylight Health Group Inc. (CVE:SLHG) Analysts Just Became A Lot More Optimistic

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to CA$2.66

Skylight Health Group Inc. to Report Q2, 2022 Results on Aug 15, 2022

Skylight Health Group Inc. announced that it expects to receive CAD 2 million in funding

Skylight Health Group Inc. Announces Board Changes

Skylight Health Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Skylight Health Group Inc. Appoints Farooq Akhter as Interim Chief Financial Officer, Effective June 15, 2022

Skylight Health Group Inc. to Report Q1, 2022 Results on May 16, 2022

Skylight Health Group Inc. (TSXV:SLHG) executed a definitive agreement to acquire NeighborMD.

Skylight Health Group Inc. announced delayed 20-F filing

Price target decreased to CA$3.90

Consensus revenue estimates fall by 22%

What You Need To Know About The Skylight Health Group Inc. (CVE:SLHG) Analyst Downgrade Today

Full year 2021 earnings: EPS and revenues miss analyst expectations

Price target decreased to CA$5.10

High number of new directors

Independent Chairman of the Board recently bought CA$59k worth of stock

President recently bought CA$54k worth of stock

Third quarter 2021 earnings released: CA$0.09 loss per share (vs CA$0.065 loss in 3Q 2020)

Price target decreased to CA$6.30

Second quarter 2021 earnings released: CA$0.11 loss per share (vs CA$0.04 loss in 2Q 2020)

No longer forecast to breakeven

Price target decreased to CA$8.40

Skylight Health Group Inc. (TSXV:SLHG) acquired ACO Partners, Inc.

Skylight Health Group Inc. (TSXV:SLHG) acquired Doctors Center Inc.

First quarter 2021 earnings released: CA$0.062 loss per share (vs CA$0.054 loss in 1Q 2020)

Skylight Health Group Inc. has completed a Follow-on Equity Offering in the amount of CAD 12.0008 million.

Price target decreased to CA$2.13

Full year 2020 earnings released: CA$0.087 loss per share (vs CA$0.14 loss in FY 2019)

Skylight Health Group Inc. Announces Management Changes

Skylight Health Group Inc. (TSXV:SHG) entered into Letters of Intent to acquire 3 Independent Primary Care Practices in the United States.

Price target raised to CA$2.31

Skylight Health Group Inc. Appoints Andrew Elinesky as Chief Financial Officer

Price target raised to CA$2.20

Skylight Health Group Inc. (TSXV:SHG) acquired River City Medical Associates.

Skylight Health Announces Executive Changes

Skylight Health Names Paul Kulas Senior Vice President of Operations

New 90-day high: CA$1.46

Skylight Health Group Inc. Begins Patient Onboarding for GatherMed Roll-Out with Insurable Reimbursement Revenue

Skylight Health Group Inc. Appoints Grace Mellis to the Board of Directors

Price target raised to CA$2.03

CB2 Insights Inc. (CNSX:CBII) completed the acquisition of assets of APEX Family Medical.

New 90-day high: CA$1.31

Skylight Health Group Inc. (CNSX:SHG) completed the acquisition of Assets of Healthcare Resources Management LLC.

Skylight Health Group Inc. has completed a Follow-on Equity Offering in the amount of CAD 12 million.

New 90-day high: CA$1.24

Skylight Health Partners with Gathermed to Launch Remote Patient Monitoring Covered Through Insurance for Patients with Hypertension

Price target raised to CA$1.27

Skylight Health Group Inc. (CNSX:SHG) entered into a letter of intent to acquire Assets of Healthcare Resources Management LLC CAD 1.03 million.

Third quarter 2020 earnings released: CA$0.013 loss per share

Third quarter 2020 earnings released: CA$0.013 loss per share

New 90-day high: CA$0.67

CB2 Insights Inc. has completed a Follow-on Equity Offering in the amount of CAD 5.0008 million.

CB2 Insights Inc. (CNSX:CBII) entered into a letter of intent to acquire assets of APEX Family Medical for CAD 2.3 million.

New 90-day high: CA$0.42

CB2 Insights Inc. (CNSX:CBII) acquired Maverick County Medical Family Center for CAD 0.98 million.

New 90-day high: CA$0.21

CB2 Insights Inc. announced that it has received CAD 5.138046 million in funding from Merida Capital Partners, LLC and other investors

CB2 Insights Inc. announced that it expects to receive CAD 3 million in funding from Merida Capital Partners, LLC

First half earnings released

CB2 Insights Inc. to Report Q2, 2020 Results on Aug 31, 2020

マネジメント基準チェック /34